MKC3946

MKC3946
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0101-1mg 1 mg -

7 - 10 business days*

60.00€
TGM-TQ0101-1mL 1 ml -

7 - 10 business days*

155.00€
TGM-TQ0101-5mg 5 mg -

7 - 10 business days*

169.00€
TGM-TQ0101-10mg 10 mg -

7 - 10 business days*

273.00€
TGM-TQ0101-25mg 25 mg -

7 - 10 business days*

458.00€
TGM-TQ0101-50mg 50 mg -

7 - 10 business days*

674.00€
TGM-TQ0101-100mg 100 mg -

7 - 10 business days*

959.00€
 
Description: MKC3946 is an effective and soluble IRE1alpha inhibitor which triggered modest... more
Product information "MKC3946"
Description: MKC3946 is an effective and soluble IRE1alpha inhibitor which triggered modest growth inhibition in multiple myeloma cell lines. Target: IRE1. Smiles: CN1CCN(CC1)C(=O)c1ccc(s1)-c1ccc2c(C=O)c(O)ccc2c1. References: Sun H, et al. Inhibition of IRE1alpha-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016 Apr 5,7(14):18736-49.
Supplier: TargetMol
Supplier-Nr: TQ0101

Properties

Application: IRE1alpha inhibitor
MW: 380.46 D
Formula: C21H20N2O3S

Database Information

CAS : 1093119-54-0| Matching products
KEGG ID : K08852 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "MKC3946"
Write a review
or to review a product.
Viewed